Seven ways COVID-19 could affect healthcare M&A:
1. More sellers than buyers will make up the post-pandemic market.
2. Hospitals that maintain some sense of solvency during the pandemic may have a larger appetite for M&A.
3. Competitors, like private equity firms and telemedicine companies, are rapidly growing as hospitals become entrenched in their COVID-19 responses.
4. Independent hospitals are working with peers in their market to best optimize care for patients, and health systems are using their scale to transfer patients, staff and supplies between facilities.
5. Resuming business after the pandemic will be difficult as staff retention and financial performance worsen, and buyers and sellers who can jump back into clinical services will be more attractive in M&A deals.
6. In general, current business combinations are still set to close as planned.
7. Some development teams at hospitals are still exploring partnerships despite the challenges.
More articles on healthcare industry transactions:
West Virginia hospital on brink of closure secures buyer
North Carolina health systems call off partnership talks
New York hospital to split with Ascension after 18 years
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
